Application and test region of vasoconstrictor assay [Regulatives / Guidelines]

posted by Kelen – Brazil, 2023-10-04 18:31 (145 d 01:44 ago) – Posting: # 23739
Views: 1,177

About vasoconstrictor assay, for products containing corticosteroids that are used in combination with other drugs to treat phimosis, considering the difference between the skins to be used in the vasoconstriction study and the skin that will be treated with the product, can we still consider the vasoconstrictor assay valid for this type of formulation?

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,635 registered users;
26 visitors (0 registered, 26 guests [including 5 identified bots]).
Forum time: 19:16 CET (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5